Scaling up Directed Graph Models for Resting-State fMRIwith Stepwise Regression

Poster submitted to the 2016 Organization for Human Brain Mapping (OHBM) in Geneva, 26-30 June

Dynamic Effective Connectivity Modelling with Multiregression Dynamic Models

Poster submitted to the 2015 Organization for Human Brain Mapping (OHBM) in Hawaii, 14-18 June

Physical Interaction between Delangin and Human MAU-2 Involves N-Terminal Binding Sites

<div><p>(A) Structure of delangin and human MAU-2 proteins and the positions of test constructs referred to in (B).</p> <p>(B) A yeast two-hybrid-based system was employed to test interaction between components of the delangin and human MAU-2 proteins as illustrated in (A) (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>). The system incorporated a β-galactosidase colony-lift filter assay so that positive interactions were scored by a blue color; colorless colonies signified no interaction. Full-length human MAU-2 was tested with different N-terminal components of delangin, spanning amino acids 1–277, amino acids 280–685, or amino acids 686–1170. Further mapping localized the N-terminal binding site to amino acids 1–139 of the delangin protein, which showed very strong interaction with an N-terminal human MAU-2 fragment spanning amino acids 1–115, but no binding to the remainder of the MAU-2 sequence from amino acids 116–613. A positive control showed interaction between murine p53 and SV40 large T-antigen expressed from constructs cloned in the vectors pGBK-T7 and pACT-2, respectively. A negative control demonstrated lack of interaction between the same vectors alone. </p></div

Human MAU-2 and Delangin Are Nuclear Proteins

<div><p>(A) Confocal microscopy studies on HeLa cells. The nuclear localization of delangin is illustrated in the top panels using a FITC-labeled secondary antibody detecting monoclonal rat anti-human delangin (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>). Panel on the right shows merging of DNA image (left panel, red) and delangin staining (center panel, green). Expression of a GFP-human MAU-2 fusion protein revealed by confocal fluorescence microscopy of transiently transfected HeLa cells is shown in the center and bottom panels. The fusion protein appears present in both the nucleus and the cytoplasm, sometimes with a strong nuclear localization, as shown in the center panels, but in other cells cytoplasmic expression predominated. Bottom panels show retention of the GFP-human MAU-2 protein in nuclei isolated from transiently transfected HeLa cells and subsequently extracted in 0.5% Triton-X. Center and bottom panels show DNA staining with TOPRO3 (left), the GFP fluorescence signal (center), and merged images (right). </p> <p>(B) Nuclear location for epitopes specific to human MAU-2. Top panel: Antisera against human MAU-2 cross reacted with four major bands in whole cell extracts from HeLa cells that had been treated with the negative (-ve) control siRNA oligonucleotide. The two bands indicated by the arrows were severely reduced in intensity (by ̃90%) when the same antisera was used to blot whole cell extracts from HeLa cells that had been subjected to human MAU-2 siRNA, using the M1 siRNA oligonucleotide (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>). Beta actin is shown as loading control. Bottom panel: HeLa cells were separated into cytoplasmic (C) and nuclear (N) fractions (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>). When these fractions were immunoblotted with human MAU-2 antisera, the bands specific to human MAU-2 were almost exclusively detected in the nuclear fraction, while the background bands appeared to be cytoplasmic. </p></div

Delangin and MAU-2 Regulate Similar Processes in Xenopus tropicalis Embryonic Development

<p>Antisense morpholino oligonucleotides (MO) were used to target specific mRNAs to inhibit production of X. tropicalis delangin or MAU-2 (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>). Embryos injected with control MO exhibit normal development (A). Embryos targeted to knock down delangin or MAU-2 both exhibit a delay in development from gastrula stages relative to control MO-injected embryos, however they look normal at this stage. By late tailbud stage (stage 28), delangin morphants (B) are severely truncated along the A-P axis and ventralized, exhibiting retarded dorsal tissue development, particularly in the neural tube and somites. Head, eye, and tail development are also defective. MAU-2 morphants (C) exhibit a very similar but less severe phenotype than is evident in delangin morphants, including shortening of the A-P axis, ventralization and defects in neural, somite, head, eye, and tail development relative to the control MO-injected embryos. </p

Human MAU-2 Regulates Sister Chromatid Cohesion and Is Required for Loading Cohesins onto Chromatin

<div><p>(A) Assay for PSCS. HeLa cells were transfected with siRNA oligonucleotides (M1 and M2) designed to knock down human MAU-2 (hMAU-2). The cells were synchronized at the G2/M stage by addition of nocodazole. After 3 h, the cells in the supernatant were collected and knockdown efficiency was assayed by immunoblotting using specific antibodies against human MAU-2. Top panel, both M1 and M2 effectively knocked down human MAU-2 (̃90% and 80% knockdown, respectively) when referenced against a negative (-ve) control oligonucleotide supplied by the manufacturer; beta actin is shown as a loading control. Metaphase spreads were prepared (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>) from these synchronized cells and assayed for PSCS separation. Middle panel, an example of PSCS in a metaphase of HeLa cells transfected with M1. Bottom panel, a metaphase from HeLa cells transfected with a negative (-ve) control oligonucleotide (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>). </p> <p>(B) By cohesin loading assay. HeLa cells transfected with a negative control oligonucleotide or subjected to human MAU-2 knockdown using the M1 oligonucleotide were synchronised in G2/M by nocodazole treatment and then released to progress into the cell cycle. Chromatin fractions prepared from aliquots collected at 0, 1.5, 2.5, and 3.5 h were subjected to Western blotting with anti-SMC3 and anti-SCC1 antibodies to monitor loading of cohesin on the chromatin. Histone H3 was used as a loading control (lower panel). The intensity of the bands was quantified as described in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>. </p> <p>(C) Left panels: Western blotting of whole Hela cell extracts that had been subjected to M1 siRNA knockdown or controls shows that the effects seen in (B) did not result from non-specific knockdown of cohesins (SMC3 and SCC1). Panels to the right: to assess the integrity of the cohesin complexes present in the supernatant, SMC3 was immunoprecipitated (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>) and co-immunoprecipitation of SCC1 was tested. The ratio of SMC3:SCC1 present in the immunoprecipitated samples is identical in negative control cells and cells subjected to human MAU-2 knockdown indicating that the integrity of the cohesin complexes is not affected. In the negative control there is a marked difference in the amount of immunoprecipitated SMC3 between time 0 and 3 h later, as in these cells cohesin gets loaded on the chromatin and there is fewer SMC3 available for immunoprecipitation in the supernatant (see B). In contrast, in cells subjected to human MAU-2 this difference is notably smaller, as in these cells cohesin fails to load on the chromatin to a comparable extent (see B). </p> <p>(D) Cohesin-loading defects observed in cells subjected to human MAU-2 knockdown are not the result of cell-cycle arrest. HeLa cells were treated as in (B) and aliquots were collected at 0 and 3.5 h. The cell-cycle profile of the cell population in each sample was analyzed by flow cytometry.</p></div

Co-Immunoprecipitation Studies Support Interaction between Delangin and Human MAU-2

<div><p>(A) Delangin co-immunoprecipitates with a GFP-human MAU-2 fusion protein. HeLa cells were transiently transfected with a GFP-human MAU-2 fusion protein construct (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>) or, as a negative control, with the GFP vector on its own. Cells were fractionated into nuclear (N) and cytoplasmic (C) fractions, and aliquots of the nuclear fractions were used for immunoprecipitation with an anti-GFP antibody to generate immunoprecipitation fractions. Individual fractions were size fractionated by SDS-PAGE and immunoblotted, using antibodies against delangin (top panel) or against GFP (bottom panel) as described in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>. The immunoprecipitation fraction from immunoprecipitating the GFP-human MAU-2 fusion protein reveals a specific band at ̃100 kDa (arrow) that is not found in the negative control sample. This is the size expected for the fusion protein (̃70 kDa for human MAU-2 and ̃ 30 kDa for GFP). The upper panel shows that the delangin antibodies identify a band of ̃ 300 kDa that is co-precipitated in the GFP-human MAU-2 immunoprecipitation sample but not in the GFP vector-only control sample. </p> <p>(B) Delangin siRNA. In order to validate the specificity of the monoclonal antibody to delangin, HeLa cells were transfected with siRNA oligonucleotides designed to knock down delangin using individual oligonucleotides D1–D3 (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0040242#s4" target="_blank">Materials and Methods</a>) or all three combined, D123. D2 produced the most effective delangin knockdown. The same band that was recognized by the antibody in the immunoprecipitation fraction (see A) was knocked down by ̃ 90% in cells transfected with the D2 siRNA oligonucleotide, when referenced against negative (−ve) and mock-transfected HeLa cell (MT) controls. </p></div

MAU-2 and PQN-85 Regulate Chromosome Segregation in Early C. elegans Embryos

<div><p>(A) Individual RNAi knockdowns. Chromosome-segregation defects are not obvious in the progeny of <i>histone::GFP</i> hermaphrodites injected with double-stranded <i>mau-2</i> RNA. However, lagging anaphase chromosomes were evident in the case of <i>pqn-85</i>(RNAi) and <i>scc-3</i>(RNAi) embryos (white arrows). </p> <p>(B) Double RNAi knockdowns. Early <i>mau-2</i> + <i>pqn-85</i> (RNAi) embryos showed chromosome lagging (white arrow) where some ensuing cells appear to be unaffected and others have multiple and misshapen nuclei (right image). Early <i>mau-2</i> + <i>scc-3</i> (RNAi) and <i>pqn-85</i> + <i>scc-3</i> (RNAi) embryos consistently showed severe chromosome segregation defects where the DNA does not appear to move to either pole. This results in the phenotype in which all cells either have multiple nuclei or have none at all. Precise assignment of cell-cycle stages was not possible because of the severity of the chromosomal phenotype. </p></div

A 71-kDa Protein Co-Purifies with FLAG-Nipped-B by Anti-FLAG Affinity Chromatography

<p>Nuclear extracts of <i>y w;</i> P[ <i>Chip-FLAG-Nipped-B, w</i>+] (FLAG) embryos and <i>y w</i> control embryos were bound to anti-FLAG beads, washed, and eluted with FLAG peptide as described in the text. FLAG-Nipped-B fusion protein was detected in the <i>y w;</i> P[ <i>Chip-FLAG-Nipped-B, w</i>+] eluate, but not in the <i>y w</i> eluate, by anti-FLAG Western blot (top panel). Other eluted proteins were detected by silver stain (bottom panel). A 71-kDa protein specific to the FLAG-Nipped-B eluate was identified by mass spectrometry as the product of the <i>Drosophila CG4203</i> gene. It is closely related to the human MAU-2 protein. Higher molecular weight bands specific to the FLAG-Nipped-B extract contain multiple proteins whose identities could not be established unambiguously. In the bottom panel, the p71 protein and several other proteins, including the markers, became doublets when the gel was dried for photography. All appeared as single bands before drying. </p